[HTML][HTML] SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis

A Rostami, M Sepidarkish, MMG Leeflang… - Clinical Microbiology …, 2021 - Elsevier
Objectives COVID-19 has been arguably the most important public health concern
worldwide in 2020, and efforts are now escalating to suppress or eliminate its spread. In this …

[HTML][HTML] Update on SARS-CoV-2 seroprevalence: regional and worldwide

A Rostami, M Sepidarkish, A Fazlzadeh… - Clinical Microbiology …, 2021 - Elsevier
Background With limited vaccine supplies, an informed position on the status of SARS-CoV-
2 infection in people can assist the prioritization of vaccine deployment. Objectives We …

Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis

N Bobrovitz, RK Arora, C Cao, E Boucher, M Liu… - PloS one, 2021 - journals.plos.org
Background Many studies report the seroprevalence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) antibodies. We aimed to synthesize seroprevalence data to …

Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies

I Bergeri, MG Whelan, H Ware, L Subissi… - PLoS …, 2022 - journals.plos.org
Background Our understanding of the global scale of Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) infection remains incomplete: Routine surveillance data …

[HTML][HTML] Global epidemiology of SARS-CoV-2 infection: a systematic review and meta-analysis of standardized population-based seroprevalence studies, Jan 2020 …

I Bergeri, M Whelan, H Ware, L Subissi, A Nardone… - MedRxiv, 2021 - medrxiv.org
Background COVID-19 case data underestimates infection and immunity, especially in low-
and middle-income countries (LMICs). We meta-analyzed standardized SARS-CoV-2 …

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis

X Chen, Z Chen, AS Azman, X Deng, R Sun… - The Lancet Global …, 2021 - thelancet.com
Background A rapidly increasing number of serological surveys for antibodies to SARS-CoV-
2 have been reported worldwide. We aimed to synthesise, combine, and assess this large …

[HTML][HTML] Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review

CC Lai, JH Wang, PR Hsueh - International Journal of Infectious Diseases, 2020 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing the coronavirus
disease 2019 (COVID-19), has led to a global pandemic. However, the majority of currently …

SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review

R Grant, T Dub, X Andrianou, H Nohynek… - BMJ open, 2021 - bmjopen.bmj.com
Objectives We aimed to review SARS-CoV-2 seroprevalence studies conducted in Europe
to understand how they may be used to inform ongoing control strategies for COVID-19 …

Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: systematic review

O Byambasuren, CC Dobler, K Bell, DP Rojas, J Clark… - PloS one, 2021 - journals.plos.org
Background Accurate seroprevalence estimates of SARS-CoV-2 in different populations
could clarify the extent to which current testing strategies are identifying all active infection …

SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey

MV Murhekar, T Bhatnagar, S Selvaraju… - The Lancet Global …, 2021 - thelancet.com
Background The first national severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) serosurvey in India, done in May–June, 2020, among adults aged 18 years or older from …